The results of our study showed that circulating levels CD235a+ PS+ RBC-derived EVs increased depending on AF presentation in T2DM patients with HF and that poor glycaemia control was associated with elevated levels of CD235a+ PS+ RBC-derived EVs. The gene discussed is GYPA; the disease is atrial fibrillation.